- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01671358
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Study Overview
Status
Conditions
Detailed Description
Studies show high touch areas maybe contaminated with organisms such as Methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant enterococci. MRSA can live on hospital surfaces for 9-14 days. Patients in rooms that were previously MRSA isolation rooms are at higher risk for developing a hospital-acquired infection.
This study is to determine if medication cabinets located outside of MRSA isolation rooms and their contents, particularly medications and the pharmacy delivery folders are at a higher risk of having MRSA colonization on them. This study will use conventional methods to determine if MRSA colonization is present and compare results between non-isolation and isolation rooms. This will evaluate if alternate measures for the reduction of MRSA colonization are needed for the MRSA isolation rooms in regards to medication delivery and storage.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26506
- West Virginia University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient rooms with isolation status for MRSA
- Patient rooms without isolation status for MRSA for 14 days
Exclusion Criteria:
- Rooms without medication cabinets directly outside the room
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Isolation Rooms for MRSA
Rooms that currently have a patient in them that are in isolation status due to MRSA
|
Non-isolation rooms
Rooms that have not been occupied by a patient in isolation due to MRSA for 14 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of MRSA colonization
Time Frame: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
Individual colonies will be removed from the plate with an inoculation loop, then streaked onto a second sheep blood agar plate.
The second plates will be incubated for 48 hours.
The colonies will then be run through standard identification tests to determine if the colonies are MRSA or not.
A comparison will be made between non-isolation and isolation rooms.
|
Hospital stay, an expected average of 14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantification of MRSA colonization
Time Frame: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
A comparison between the sites of swabbing will be performed.
|
Hospital stay, an expected average of 14 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of other bacterial colonization
Time Frame: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
Individual colonies will be removed from the plate with an inoculation loop, then streaked onto a second sheep blood agar plate.
The second plates will be incubated for 48 hours.
The colonies will be categorized as gram negative, gram positive catalase negative, Gram positive coagulase negative Staphylococcus species or methicillin-sensitive Staphylococcus aureus.
This will serve as a baseline epidemiology of the hospital and generate other possible hypotheses.
|
Hospital stay, an expected average of 14 days
|
Correlation between MRSA and active infection or colonization of patient
Time Frame: Hospital stay, an expected average of 14 days
|
The patient from the same time frame in the rooms sampled and positive for MRSA colonization will be reviewed to determine if they had active infection or were previously colonized.
|
Hospital stay, an expected average of 14 days
|
Correlation between colonization of other positive organisms and active infection or colonization of patient
Time Frame: Hospital stay, an expected average of 14 days
|
The patient from the same time frame in the rooms sampled and positive for non-MRSA colonization will be reviewed to determine if they had active infection or were previously colonized.
|
Hospital stay, an expected average of 14 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Bures S, Fishbain JT, Uyehara CF, Parker JM, Berg BW. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control. 2000 Dec;28(6):465-71. doi: 10.1067/mic.2000.107267.
- Sexton T, Clarke P, O'Neill E, Dillane T, Humphreys H. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect. 2006 Feb;62(2):187-94. doi: 10.1016/j.jhin.2005.07.017. Epub 2005 Nov 14.
- Oie S, Hosokawa I, Kamiya A. Contamination of room door handles by methicillin-sensitive/methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2002 Jun;51(2):140-3. doi: 10.1053/jhin.2002.1221.
- Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006 Oct 9;166(18):1945-51. doi: 10.1001/archinte.166.18.1945.
- Huang R, Mehta S, Weed D, Price CS. Methicillin-resistant Staphylococcus aureus survival on hospital fomites. Infect Control Hosp Epidemiol. 2006 Nov;27(11):1267-9. doi: 10.1086/507965. Epub 2006 Sep 28.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WVU-00010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Methicillin-Resistant Staphylococcus Aureus
-
University of Colorado, DenverAmerican Academy of Family Physicians National Research NetworkCompletedMethicillin-Resistant Staphylococcus AureusUnited States
-
University Hospital, ToulouseCompletedMethicillin-Resistant Staphylococcus AureuS
-
University of Sao PauloUnknownMethicillin Resistant Staphylococcus AureusBrazil
-
University of Lausanne HospitalsCompletedMethicillin-Resistant Staphylococcus Aureus
-
NorthShore University HealthSystemAgency for Healthcare Research and Quality (AHRQ)CompletedMethicillin Resistant Staphylococcus AureusUnited States
-
University of California, IrvineAgency for Healthcare Research and Quality (AHRQ)CompletedMethicillin-Resistant Staphylococcus AureusUnited States
-
Pinyo RattanaumpawanUnknownMethicillin-Resistant Staphylococcus AureusThailand
-
Mercy ResearchWithdrawnMethicillin-Resistant Staphylococcus Aureus
-
Assistance Publique - Hôpitaux de ParisCompletedAntibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients (StaphMRG)Methicillin Resistant Staphylococcus AureusFrance
-
University of FloridaRecruitingMethicillin-Resistant Staphylococcus AureusUnited States